Publications by authors named "Julio Cesar Ramirez Nava"
Article Synopsis
- * In rats, sucrose was co-administered with a carcinogen (DEN), resulting in changes to body and organ weights, as well as fat levels in the blood.
- * Surprisingly, sucrose not only improved liver health, reducing fibrosis and tumor growth, but also led to lower tumor marker levels and affected gene expression related to fat metabolism and stress response, suggesting a protective effect against liver cancer.
Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome.
Sinuhé Raúl Cruz-Villanueva Julio César Ramirez-Nava Juan Antonio Moreno-Luna Karime Guadalupe Cárdenas-Ureña Luz Teresa Espín-Iturbe
J Nutr Sci Vitaminol (Tokyo)
November 2021
Metabolic syndrome (MS) is a combination of risk factors related to the development of mainly type 2 diabetes mellitus, cardiovascular disease (CVD) and nonalcoholic fatty liver disease (NAFLD). Its prevalence has increased worldwide, and healthcare systems will face major challenges in addressing this problem. The aim of this work was to evaluate the effect of hyperbaric oxygen therapy (HBOT) on insulin resistance (IR) and obesity associated with MS in Wistar rats.
View Article and Find Full Text PDFArticle Synopsis
- Diabetic kidney disease (DKD) is a common complication of diabetes, and this study aimed to evaluate the impact of hyperbaric oxygen (HBO2) therapy on kidney function in diabetic patients.
- In the study, patients with stage 3 and 4 DKD received either HBO2 or ambient air, with significant improvements noted in the experimental group, including reduced urinary albumin excretion and increased glomerular filtration rate (GFR).
- The results indicated that HBO2 therapy was effective in lowering urinary albumin levels and enhancing kidney function compared to the control group, suggesting it could be a beneficial treatment for patients with advanced DKD.